All Stories

  1. Approach to dealing with acute heart failure in cats and dogs
  2. Prevalence of gastroesophageal reflux in dogs undergoing MRI for a thoracolumbar vertebral column pathology
  3. Heart rate variability during high‐speed treadmill exercise and recovery in Thoroughbred racehorses presented for poor performance
  4. Improved Ca2+ release synchrony following selective modification of Itof and phase 1 repolarization in normal and failing ventricular myocytes
  5. Validation of a focused echocardiographic training program in first opinion practice
  6. 21st century research—One Health, resilience, welfare, and disease
  7. Training the equine respiratory muscles: Inspiratory muscle strength
  8. The microvascular endothelial glycocalyx: An additional piece of the puzzle in veterinary medicine
  9. Circulating hyaluronan as a marker of endothelial glycocalyx damage in dogs with myxomatous mitral valve disease and dogs in a hypercoagulable state
  10. Training the equine respiratory muscles: Ultrasonographic measurement of muscle size
  11. The prevalence of ultrasonographic gastrointestinal wall changes in dogs with acute pancreatitis - a retrospective study (2012-2020)
  12. Calculation of myocardial percentage collagen and mast cell count in dogs with myxomatous mitral valve disease and control dogs – a pilot study
  13. Three-Dimensional Printed Models of the Heart Represent an Opportunity for Inclusive Learning
  14. Prevalence of ultrasonographic gastrointestinal wall changes in dogs with acute pancreatitis: A retrospective study (2012‐2020)
  15. Effect of preoperative administration of atenolol to dogs with pulmonic stenosis undergoing interventional procedures
  16. Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice
  17. Transvalvular pulmonic stent angioplasty: procedural outcomes and complications in 15 dogs with pulmonic stenosis
  18. Diagnostic Rounds: ECG 101
  19. Computed tomographic staging of dogs with anal sac adenocarcinoma
  20. Clinical findings associated with N‐terminal pro‐B‐type natriuretic peptide measurement in dogs and cats attending first opinion veterinary practices
  21. Inspiratory muscle training for the treatment of dynamic upper airway collapse in racehorses: A preliminary investigation
  22. Evaluation of serum cardiac troponin‐ I concentrations for diagnosis of infective endocarditis in dogs
  23. DETERMINATION OF VERTEBRAL HEART SCALE AND ECHOCARDIOGRAPHIC MEASUREMENTS IN HEALTHY ANESTHETIZED AFRICAN WILD DOGS (LYCAON PICTUS) IN HUMAN CARE
  24. The equine diaphragm: A novel technique for repeatable ultrasound measurement
  25. Focused cardiac ultrasound and point‐of‐care NT‐proBNP assay in the emergency room for differentiation of cardiac and noncardiac causes of respiratory distress in cats
  26. PetSavers
  27. Monitoring congestive heart failure
  28. Long‐term biological variability and the generation of a new reference interval for plasma N‐terminal pro‐B‐type natriuretic peptide in Labrador retrievers
  29. Investigation of focused cardiac ultrasound in the emergency room for differentiation of respiratory and cardiac causes of respiratory distress in dogs
  30. Arrhythmogenic late Ca 2+ sparks in failing heart cells and their control by action potential configuration
  31. Measurements of echocardiographic indices and biomarkers of kidney injury in dogs with chronic kidney disease
  32. What can changes in serial measurements tell us about prognosis in myxomatous mitral valve disease?
  33. Correction: Is treatment with pimobendan associated with an increased risk of arrhythmias in dogs with heart disease?
  34. Exploring early life events including diet in cats presenting for gastrointestinal signs in later life
  35. A new hope? Transvascular pulmonic stents in six dogs with severe pulmonic stenosis
  36. Is treatment with pimobendan associated with an increased risk of arrhythmias in dogs with heart disease?
  37. Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease
  38. Sample Size Determination for Evaluation of Time Domain Heart Rate Variability Indices in Canine Lameness
  39. Pathology and prognosis of canine myxomatous mitral valve disease
  40. Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone—a pilot study
  41. Anodal stimulation in two dogs with transvenous permanent bipolar pacemakers
  42. Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second‐Generation Quantitative and Point‐of‐Care NT ‐pro BNP Measurements
  43. Clinical Severity Score System in Dogs with Degenerative Mitral Valve Disease
  44. The effects of storage conditions on measurements of canine N-terminal pro-B-type natriuretic peptide
  45. Associations between N-terminal procollagen type III, fibrosis and echocardiographic indices in dogs that died due to myxomatous mitral valve disease
  46. Relationship of Plasma N-terminal Pro-brain Natriuretic Peptide Concentrations to Heart Failure Classification and Cause of Respiratory Distress in Dogs Using a 2nd Generation ELISA Assay
  47. Longitudinal Electrocardiographic Evaluation of Dogs with Degenerative Mitral Valve Disease
  48. Differentiating between feline pleural effusions of cardiac and non-cardiac origin using pleural fluid NT-proBNP concentrations
  49. Relationships between heart rate and age, bodyweight and breed in 10,849 dogs
  50. Relationships between heart rate and age, bodyweight and breed in 10,849 dogs
  51. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease
  52. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease
  53. Ultrasonographic measurement of flow-mediated vasodilation in dogs with chronic valvular disease
  54. The Combined Prognostic Potential of Serum High-Sensitivity Cardiac Troponin I and N-Terminal pro-B-Type Natriuretic Peptide Concentrations in Dogs with Degenerative Mitral Valve Disease
  55. Gerbode defect associated with blunt trauma in a dog
  56. The effect of protease inhibition on the temporal stability of NT-proBNP in feline plasma at room temperature
  57. Laboratory evaluation of cardiac disease
  58. Investigating the endothelial glycocalyx in health and disease in dogs